Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02532621 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]
A NA study, sponsored by Phraxis.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT02532621 is a NA study that has completed, run by Phraxis. The registered enrollment target is 158 participants.
The verdict
NCT02532621, a NA study, has completed, sponsored by Phraxis.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The InterGraft™ Venous Anastomotic Connector provides an endovascular, minimally invasive means for attachment of an arteriovenous graft to a vein in the upper extremity. The InterGraft™ Venous Anastomotic Connector facilitates creation of the arteriovenous graft connection to a vein in support of hemodialysis in subjects with End Stage Renal Disease. The InterGraft™ Venous Anastomotic Connector is used together with conventional suturing of the arterial anastomosis to facilitate creation of an arteriovenous graft in support of hemodialysis in subjects with End Stage Renal Disease.
Interventions
- DEVICE Venous InterGraft Connector
- PROCEDURE sutured arterial anastomosis of an implanted vascular graft for hemodialysis
- PROCEDURE hemodialysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2022-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02532621
The ClinicalTrials.gov registry entry for NCT02532621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phraxis, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Venous InterGraft Connector is the first listed.
NCT02532621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02532621 about?
NCT02532621 is a clinical study titled "Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]". The InterGraft™ Venous Anastomotic Connector provides an endovascular, minimally invasive means for attachment of an arteriovenous graft to a vein in the upper extremity. The InterGraft™ Venous Anastomotic Connector facilitates creation of the arteriovenous graft connection to a vein in support of h...
What is the current status of trial NCT02532621?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2018-02-21. Estimated completion is 2022-01-19.
What interventions are being tested in trial NCT02532621?
The interventions under investigation include: Venous InterGraft Connector (DEVICE), sutured arterial anastomosis of an implanted vascular graft for hemodialysis (PROCEDURE), hemodialysis (PROCEDURE).
Who is sponsoring clinical trial NCT02532621?
This trial is sponsored by Phraxis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.